Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression
Display Omitted
Gespeichert in:
| Autor*in: |
Patil, Naeem K. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
15 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China - Deng, Lixing ELSEVIER, 2022, the official journal of the Italian Pharmacological Society, London |
|---|---|
| Übergeordnetes Werk: |
volume:111 ; year:2016 ; pages:688-702 ; extent:15 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.phrs.2016.07.019 |
|---|
| Katalog-ID: |
ELV035482737 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV035482737 | ||
| 003 | DE-627 | ||
| 005 | 20230624022517.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.phrs.2016.07.019 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000028.pica |
| 035 | |a (DE-627)ELV035482737 | ||
| 035 | |a (ELSEVIER)S1043-6618(16)30685-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 330 |q VZ |
| 100 | 1 | |a Patil, Naeem K. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression |
| 264 | 1 | |c 2016 | |
| 300 | |a 15 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Immunosuppression |2 Elsevier | |
| 650 | 7 | |a IFN-γ |2 Elsevier | |
| 650 | 7 | |a Anti-PD-1 |2 Elsevier | |
| 650 | 7 | |a Flt3 ligand |2 Elsevier | |
| 650 | 7 | |a Immunotherapy |2 Elsevier | |
| 650 | 7 | |a T cell |2 Elsevier | |
| 650 | 7 | |a Anti-PD-L1 |2 Elsevier | |
| 650 | 7 | |a Biomarkers |2 Elsevier | |
| 650 | 7 | |a Sepsis |2 Elsevier | |
| 650 | 7 | |a Interleukin-15 |2 Elsevier | |
| 650 | 7 | |a Interleukin-7 |2 Elsevier | |
| 700 | 1 | |a Bohannon, Julia K. |4 oth | |
| 700 | 1 | |a Sherwood, Edward R. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Academic Press |a Deng, Lixing ELSEVIER |t Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |d 2022 |d the official journal of the Italian Pharmacological Society |g London |w (DE-627)ELV008224951 |
| 773 | 1 | 8 | |g volume:111 |g year:2016 |g pages:688-702 |g extent:15 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.phrs.2016.07.019 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 111 |j 2016 |h 688-702 |g 15 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
n k p nk nkp |
|---|---|
| matchkey_str |
patilnaeemkbohannonjuliaksherwoodedwardr:2016----:muohrparmsnapoctrvreessnu |
| hierarchy_sort_str |
2016 |
| publishDate |
2016 |
| allfields |
10.1016/j.phrs.2016.07.019 doi GBV00000000000028.pica (DE-627)ELV035482737 (ELSEVIER)S1043-6618(16)30685-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Patil, Naeem K. verfasserin aut Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression 2016 15 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Immunosuppression Elsevier IFN-γ Elsevier Anti-PD-1 Elsevier Flt3 ligand Elsevier Immunotherapy Elsevier T cell Elsevier Anti-PD-L1 Elsevier Biomarkers Elsevier Sepsis Elsevier Interleukin-15 Elsevier Interleukin-7 Elsevier Bohannon, Julia K. oth Sherwood, Edward R. oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:111 year:2016 pages:688-702 extent:15 https://doi.org/10.1016/j.phrs.2016.07.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 111 2016 688-702 15 045F 610 |
| spelling |
10.1016/j.phrs.2016.07.019 doi GBV00000000000028.pica (DE-627)ELV035482737 (ELSEVIER)S1043-6618(16)30685-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Patil, Naeem K. verfasserin aut Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression 2016 15 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Immunosuppression Elsevier IFN-γ Elsevier Anti-PD-1 Elsevier Flt3 ligand Elsevier Immunotherapy Elsevier T cell Elsevier Anti-PD-L1 Elsevier Biomarkers Elsevier Sepsis Elsevier Interleukin-15 Elsevier Interleukin-7 Elsevier Bohannon, Julia K. oth Sherwood, Edward R. oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:111 year:2016 pages:688-702 extent:15 https://doi.org/10.1016/j.phrs.2016.07.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 111 2016 688-702 15 045F 610 |
| allfields_unstemmed |
10.1016/j.phrs.2016.07.019 doi GBV00000000000028.pica (DE-627)ELV035482737 (ELSEVIER)S1043-6618(16)30685-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Patil, Naeem K. verfasserin aut Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression 2016 15 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Immunosuppression Elsevier IFN-γ Elsevier Anti-PD-1 Elsevier Flt3 ligand Elsevier Immunotherapy Elsevier T cell Elsevier Anti-PD-L1 Elsevier Biomarkers Elsevier Sepsis Elsevier Interleukin-15 Elsevier Interleukin-7 Elsevier Bohannon, Julia K. oth Sherwood, Edward R. oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:111 year:2016 pages:688-702 extent:15 https://doi.org/10.1016/j.phrs.2016.07.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 111 2016 688-702 15 045F 610 |
| allfieldsGer |
10.1016/j.phrs.2016.07.019 doi GBV00000000000028.pica (DE-627)ELV035482737 (ELSEVIER)S1043-6618(16)30685-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Patil, Naeem K. verfasserin aut Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression 2016 15 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Immunosuppression Elsevier IFN-γ Elsevier Anti-PD-1 Elsevier Flt3 ligand Elsevier Immunotherapy Elsevier T cell Elsevier Anti-PD-L1 Elsevier Biomarkers Elsevier Sepsis Elsevier Interleukin-15 Elsevier Interleukin-7 Elsevier Bohannon, Julia K. oth Sherwood, Edward R. oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:111 year:2016 pages:688-702 extent:15 https://doi.org/10.1016/j.phrs.2016.07.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 111 2016 688-702 15 045F 610 |
| allfieldsSound |
10.1016/j.phrs.2016.07.019 doi GBV00000000000028.pica (DE-627)ELV035482737 (ELSEVIER)S1043-6618(16)30685-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Patil, Naeem K. verfasserin aut Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression 2016 15 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Immunosuppression Elsevier IFN-γ Elsevier Anti-PD-1 Elsevier Flt3 ligand Elsevier Immunotherapy Elsevier T cell Elsevier Anti-PD-L1 Elsevier Biomarkers Elsevier Sepsis Elsevier Interleukin-15 Elsevier Interleukin-7 Elsevier Bohannon, Julia K. oth Sherwood, Edward R. oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:111 year:2016 pages:688-702 extent:15 https://doi.org/10.1016/j.phrs.2016.07.019 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 111 2016 688-702 15 045F 610 |
| language |
English |
| source |
Enthalten in Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China London volume:111 year:2016 pages:688-702 extent:15 |
| sourceStr |
Enthalten in Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China London volume:111 year:2016 pages:688-702 extent:15 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Immunosuppression IFN-γ Anti-PD-1 Flt3 ligand Immunotherapy T cell Anti-PD-L1 Biomarkers Sepsis Interleukin-15 Interleukin-7 |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| authorswithroles_txt_mv |
Patil, Naeem K. @@aut@@ Bohannon, Julia K. @@oth@@ Sherwood, Edward R. @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV008224951 |
| dewey-sort |
3610 |
| id |
ELV035482737 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV035482737</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624022517.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.phrs.2016.07.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000028.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV035482737</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1043-6618(16)30685-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Patil, Naeem K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">15</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunosuppression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IFN-γ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-PD-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Flt3 ligand</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">T cell</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-PD-L1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biomarkers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sepsis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Interleukin-15</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Interleukin-7</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bohannon, Julia K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sherwood, Edward R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Deng, Lixing ELSEVIER</subfield><subfield code="t">Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the Italian Pharmacological Society</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV008224951</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:111</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:688-702</subfield><subfield code="g">extent:15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.phrs.2016.07.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">111</subfield><subfield code="j">2016</subfield><subfield code="h">688-702</subfield><subfield code="g">15</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Patil, Naeem K. |
| spellingShingle |
Patil, Naeem K. ddc 610 ddc 330 Elsevier Immunosuppression Elsevier IFN-γ Elsevier Anti-PD-1 Elsevier Flt3 ligand Elsevier Immunotherapy Elsevier T cell Elsevier Anti-PD-L1 Elsevier Biomarkers Elsevier Sepsis Elsevier Interleukin-15 Elsevier Interleukin-7 Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression |
| authorStr |
Patil, Naeem K. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008224951 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 330 - Economics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 330 VZ Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression Immunosuppression Elsevier IFN-γ Elsevier Anti-PD-1 Elsevier Flt3 ligand Elsevier Immunotherapy Elsevier T cell Elsevier Anti-PD-L1 Elsevier Biomarkers Elsevier Sepsis Elsevier Interleukin-15 Elsevier Interleukin-7 Elsevier |
| topic |
ddc 610 ddc 330 Elsevier Immunosuppression Elsevier IFN-γ Elsevier Anti-PD-1 Elsevier Flt3 ligand Elsevier Immunotherapy Elsevier T cell Elsevier Anti-PD-L1 Elsevier Biomarkers Elsevier Sepsis Elsevier Interleukin-15 Elsevier Interleukin-7 |
| topic_unstemmed |
ddc 610 ddc 330 Elsevier Immunosuppression Elsevier IFN-γ Elsevier Anti-PD-1 Elsevier Flt3 ligand Elsevier Immunotherapy Elsevier T cell Elsevier Anti-PD-L1 Elsevier Biomarkers Elsevier Sepsis Elsevier Interleukin-15 Elsevier Interleukin-7 |
| topic_browse |
ddc 610 ddc 330 Elsevier Immunosuppression Elsevier IFN-γ Elsevier Anti-PD-1 Elsevier Flt3 ligand Elsevier Immunotherapy Elsevier T cell Elsevier Anti-PD-L1 Elsevier Biomarkers Elsevier Sepsis Elsevier Interleukin-15 Elsevier Interleukin-7 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j k b jk jkb e r s er ers |
| hierarchy_parent_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| hierarchy_parent_id |
ELV008224951 |
| dewey-tens |
610 - Medicine & health 330 - Economics |
| hierarchy_top_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008224951 |
| title |
Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression |
| ctrlnum |
(DE-627)ELV035482737 (ELSEVIER)S1043-6618(16)30685-5 |
| title_full |
Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression |
| author_sort |
Patil, Naeem K. |
| journal |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| journalStr |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
688 |
| author_browse |
Patil, Naeem K. |
| container_volume |
111 |
| physical |
15 |
| class |
610 610 DE-600 330 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Patil, Naeem K. |
| doi_str_mv |
10.1016/j.phrs.2016.07.019 |
| dewey-full |
610 330 |
| title_sort |
immunotherapy: a promising approach to reverse sepsis-induced immunosuppression |
| title_auth |
Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression |
| url |
https://doi.org/10.1016/j.phrs.2016.07.019 |
| remote_bool |
true |
| author2 |
Bohannon, Julia K. Sherwood, Edward R. |
| author2Str |
Bohannon, Julia K. Sherwood, Edward R. |
| ppnlink |
ELV008224951 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.phrs.2016.07.019 |
| up_date |
2024-07-06T17:40:38.036Z |
| _version_ |
1803852330341236736 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV035482737</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624022517.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.phrs.2016.07.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000028.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV035482737</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1043-6618(16)30685-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Patil, Naeem K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">15</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunosuppression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IFN-γ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-PD-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Flt3 ligand</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">T cell</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-PD-L1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biomarkers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sepsis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Interleukin-15</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Interleukin-7</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bohannon, Julia K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sherwood, Edward R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Deng, Lixing ELSEVIER</subfield><subfield code="t">Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the Italian Pharmacological Society</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV008224951</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:111</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:688-702</subfield><subfield code="g">extent:15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.phrs.2016.07.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">111</subfield><subfield code="j">2016</subfield><subfield code="h">688-702</subfield><subfield code="g">15</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.39896 |